About Thinq Pharma-Cro Limited
Data last updated: 08 January 2026
Thinq Pharma-Cro Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 November 2006, the company has been in operation for over 20 years.
Registered with ROC Mumbai under CIN U24239MH2006PLC165473.
Capital: an authorised share capital of ₹25 Lakh and a paid-up capital of ₹5.01 Lakh. It is led by directors including Chandrashekhar Shankar Nadkarni and Ravindra Ramakant Gulgule.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: D – 3 1St Floor Daginawala Mansion S. B. Rd Mahim – West, Mumbai, Maharashtra, India – 400016.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.89 Cr, a growth of 17% compared to the previous year.
The company has a workforce of approximately 148 employees as per the latest available data.
The company is associated with 1 brand - Thinq Pharma. As per MCA filings, the company has open charges of ₹48.38 Cr and satisfied charges of ₹85.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thinqcro.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressD – 3 1St Floor Daginawala Mansion S. B. Rd Mahim – West, Mumbai, Maharashtra, India – 400016
-
IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited operates one associated brand: THINQ Pharma. These brands represent Thinq Pharma-Cro Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations, APIs, and offers R&D and regulatory services worldwide. | thinqcro.com |
Competitors & Alternatives of Thinq Pharma-Cro Limited
Brands and companies operating in the same space as Thinq Pharma-Cro Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited is engaged in principal business activities including manufacturing and support service to organizations, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other support services to organizations. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details for Thinq Pharma-Cro Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited is audited by G. J. SHAH & COMPANY for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G. J. SHAH & COMPANY | Locked | Locked | Locked |
Complete auditor history for Thinq Pharma-Cro Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrashekhar Shankar Nadkarni | Managing Director | 10 Nov 2006 | 19 Years 8 Months | Current |
|
Ravindra Ramakant Gulgule
Also directs:
Phamunico Llp, Moringa Frontiers Private Limited
|
Director | 15 Sep 2011 | 14 Years 10 Months | Current |
| Rohit Ramakant Gulgule | Director | 10 Nov 2006 | 19 Years 8 Months | Current |
Financials of Thinq Pharma-Cro Limited FY 2025 filings available
Thinq Pharma-Cro Limited reported revenue of ₹62.89 Cr (up 17.00% YoY) for FY 2025.
Ten-year financial statements for Thinq Pharma-Cro Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Thinq Pharma-Cro Limited
Shareholding and ownership data for Thinq Pharma-Cro Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Thinq Pharma-Cro Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2025 | Others | ₹1.44 Cr | Open |
| 30 Oct 2025 | Standard Chartered Bank | ₹8.5 Cr | Open |
| 17 Jun 2025 | Standard Chartered Bank | ₹12 Cr | Open |
| 30 Jan 2025 | Others | ₹74.21 Lakh | Open |
| 08 Feb 2024 | Others | ₹5.7 Cr | Open |
Total charge records: 21 View all charges
Employees and EPFO Compliance at Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited has a workforce of 148 employees as of Nov 07, 2025.
Employee and EPFO history for Thinq Pharma-Cro Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Thinq Pharma-Cro Limited
GST registrations and filing compliance for Thinq Pharma-Cro Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Thinq Pharma-Cro Limited
Credit ratings, litigation, and regulatory alerts for Thinq Pharma-Cro Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Thinq Pharma-Cro Limited
MSME payment history for Thinq Pharma-Cro Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Thinq Pharma-Cro Limited
Corporate group structure for Thinq Pharma-Cro Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Thinq Pharma-Cro Limited
MCA filings and documents for Thinq Pharma-Cro Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Thinq Pharma-Cro Limited
Frequently Asked Questions about Thinq Pharma-Cro Limited
Thinq Pharma-Cro Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 10 November 2006 (20+ years old) and is registered under CIN U24239MH2006PLC165473. The company has 148 employees.
Thinq Pharma-Cro Limited reported revenue of ₹62.89 Cr for FY 2025 (up 17.00% YoY).
The current directors of Thinq Pharma-Cro Limited are:
- Chandrashekhar Shankar Nadkarni - Managing Director
- Ravindra Ramakant Gulgule - Director
- Rohit Ramakant Gulgule - Director
The primary industry of Thinq Pharma-Cro Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Thinq Pharma-Cro Limited can be reached at the registered office: D – 3 1St Floor Daginawala Mansion S. B. Rd Mahim – West, Mumbai, Maharashtra, India – 400016, or through the website thinqcro.com.
The authorised capital is ₹25 Lakh, and the paid-up capital is ₹5.01 Lakh.